Literature DB >> 7388538

Suspected anaphylactic reaction to Cremophor EL.

D Dye, J Watkins.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7388538      PMCID： PMC1601823          DOI： 10.1136/bmj.280.6228.1353

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

Review 1.  Anaphylactoid reactions to i.v. substances.

Authors:  J Watkins
Journal:  Br J Anaesth       Date:  1979-01       Impact factor: 9.166

2.  Immune-mediated reactions to althesin (alphaxalone).

Authors:  J Watkins; A Clark; T N Appleyard; A Padfield
Journal:  Br J Anaesth       Date:  1976-09       Impact factor: 9.166

3.  Complement-mediated reactions to diazepam with Cremophor as solvent (Stesolid MR).

Authors:  M S Hüttel; A Schou Olesen; E Stoffersen
Journal:  Br J Anaesth       Date:  1980-01       Impact factor: 9.166

4.  An animal model for the investigation of adverse responses to i.v. anesthetic agents and their solvents.

Authors:  J B Glen; G E Davies; D S Thomson; S C Scarth; A V Thompson
Journal:  Br J Anaesth       Date:  1979-09       Impact factor: 9.166
  4 in total
  35 in total

1.  Pharmacokinetics of silybin nanoparticles in mice bearing SKOV-3 human ovarian carcinoma xenocraft.

Authors:  Xin-Lei Guan; Shu-Zhen Zhao; Rui-Jie Hou; Sheng-Hua Yang; Quan-Le Zhang; Shan-Lan Yin; Shi-Jin Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 3.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

4.  Mechanisms of hypersensitivity to intravenous agents.

Authors:  J Watkins
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

5.  Comparative responses to propofol anaesthesia alone and with alpha 2-adrenergic medications in a canine model.

Authors:  A Bufalari; C E Short; C Giannoni; O Vainio
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

6.  Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats.

Authors:  May P Xiong; Jaime A Yáñez; Connie M Remsberg; Yusuke Ohgami; Glen S Kwon; Neal M Davies; M Laird Forrest
Journal:  J Control Release       Date:  2008-03-25       Impact factor: 9.776

7.  Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel.

Authors:  Adam W G Alani; Younsoo Bae; Deepa A Rao; Glen S Kwon
Journal:  Biomaterials       Date:  2009-12-03       Impact factor: 12.479

Review 8.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.

Authors:  José Hureaux; Frédéric Lagarce; Frédéric Gagnadoux; Marie-Christine Rousselet; Valérie Moal; Thierry Urban; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2010-03       Impact factor: 4.200

10.  Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

Authors:  Ho-Chul Shin; Adam W G Alani; Deepa A Rao; Nicole C Rockich; Glen S Kwon
Journal:  J Control Release       Date:  2009-05-04       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.